News
Nobel Biocare, Straumann Fall as UBS Cuts Forecasts
www.bloomberg.com
Oct 12, — ... down from previous estimates of 4 percent and 6 percent, Maja Pataki, a UBS analyst in Zurich, wrote in a report today. › news › articles › nobel-b...
Galenica Santé lève CHF 1,9 md, plus grosse IPO de en ...
investir.lesechos.fr
Apr 7, — ... la faible exposition aux changes et la croissance stable des bénéfices", écrit Maja Pataki, analyste de Kepler Cheuvreux, dans une note. › actualites
UPDATE 1-Straumann raises sales growth target after strong ...
www.reuters.com
Aug 23, — “Momentum continues to be very strong for Straumann, and we expect this to continue,” Kepler Cheuvreux analyst Maja Pataki wrote in a note. › article › straumann-results
Aufteilung von Galenica schafft Mehrwert | Börsen-Zeitung
www.boersen-zeitung.de
... gesteht Maja Pataki vom Zürcher Wertpapiermakler Kepler Cheuvreux Frist zuverlässig hohe Dividenden ausschütten kann", erklärt Maja Pataki. › kap...
sorted by relevance / date